Klatskin Tumor

MACC1 gene is independent prognostic biomarker for survival in patients with Klatskin tumor

By

Bile duct cancer is rare and usually detected too late; therefore, often only extensive liver surgery or, in rare cases, liver transplantation can help. Using the oncogene MACC1 as a biomarker, physicians now have a tool to help them decide if which surgical option is best for patients with one type of bile duct cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs